BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

667 related articles for article (PubMed ID: 35079699)

  • 1. Incidence of hepatocellular carcinoma in a community-based Taiwanese population without chronic HBV/HCV infection.
    Wu HC; Jeng WJ; Pan MH; Hsieh YC; Lu SN; Chen CJ; Yang HI
    JHEP Rep; 2022 Feb; 4(2):100410. PubMed ID: 35079699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural history of chronic hepatitis B REVEALed.
    Chen CJ; Yang HI
    J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Level of Hepatitis B Core-Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load.
    Tseng TC; Liu CJ; Hsu CY; Hong CM; Su TH; Yang WT; Chen CL; Yang HC; Huang YT; Fang-Tzu Kuo S; Liu CH; Chen PJ; Chen DS; Kao JH
    Gastroenterology; 2019 Dec; 157(6):1518-1529.e3. PubMed ID: 31470004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in decompensated cirrhosis and hepatocellular carcinoma among people with a hepatitis B notification in New South Wales.
    Shah SHBU; Alavi M; Hajarizadeh B; Matthews GV; Martinello M; Danta M; Amin J; Law MG; George J; Valerio H; Dore GJ
    JHEP Rep; 2022 Oct; 4(10):100552. PubMed ID: 36119722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.
    Chen CJ; Yang HI; Su J; Jen CL; You SL; Lu SN; Huang GT; Iloeje UH;
    JAMA; 2006 Jan; 295(1):65-73. PubMed ID: 16391218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiplicative synergistic risk of hepatocellular carcinoma development among hepatitis B and C co-infected subjects in HBV endemic area: a community-based cohort study.
    Oh JK; Shin HR; Lim MK; Cho H; Kim DI; Jee Y; Yun H; Yoo KY
    BMC Cancer; 2012 Oct; 12():452. PubMed ID: 23039099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effects of family history of hepatocellular carcinoma and hepatitis B virus infection on risk for incident hepatocellular carcinoma.
    Loomba R; Liu J; Yang HI; Lee MH; Lu SN; Wang LY; Iloeje UH; You SL; Brenner D; Chen CJ;
    Clin Gastroenterol Hepatol; 2013 Dec; 11(12):1636-45.e1-3. PubMed ID: 23669307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes mellitus, metabolic syndrome and obesity are not significant risk factors for hepatocellular carcinoma in an HBV- and HCV-endemic area of Southern Taiwan.
    Chen CT; Chen JY; Wang JH; Chang KC; Tseng PL; Kee KM; Chen PF; Tsai LS; Chen SC; Lin SC; Lu SN
    Kaohsiung J Med Sci; 2013 Aug; 29(8):451-9. PubMed ID: 23906236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of clinical outcomes and impact of SVR in American and Chinese patients with chronic hepatitis C.
    Rao H; Liu H; Wu E; Yang M; Feng B; Lin A; Fei R; Fontana RJ; Wei L; Lok AS
    JHEP Rep; 2020 Aug; 2(4):100136. PubMed ID: 32715286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of Metabolic Risk Factors on Risk of Hepatocellular Carcinoma and Liver-Related Death in Men With Chronic Hepatitis B: A Large Cohort Study.
    Yu MW; Lin CL; Liu CJ; Yang SH; Tseng YL; Wu CF
    Gastroenterology; 2017 Oct; 153(4):1006-1017.e5. PubMed ID: 28711626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death.
    Chen JD; Yang HI; Iloeje UH; You SL; Lu SN; Wang LY; Su J; Sun CA; Liaw YF; Chen CJ;
    Gastroenterology; 2010 May; 138(5):1747-54. PubMed ID: 20114048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in hepatocellular carcinoma among people with HBV or HCV notification in Australia (2000-2014).
    Waziry R; Grebely J; Amin J; Alavi M; Hajarizadeh B; George J; Matthews GV; Law M; Dore GJ
    J Hepatol; 2016 Dec; 65(6):1086-1093. PubMed ID: 27569777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of hepatocellular carcinoma and habits of alcohol drinking, betel quid chewing and cigarette smoking: a cohort of 2416 HBsAg-seropositive and 9421 HBsAg-seronegative male residents in Taiwan.
    Wang LY; You SL; Lu SN; Ho HC; Wu MH; Sun CA; Yang HI; Chien-Jen C
    Cancer Causes Control; 2003 Apr; 14(3):241-50. PubMed ID: 12814203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of hospitalization for infection among patients with hepatitis B or C virus infection without cirrhosis in Taiwan: A cohort study.
    Lee YC; Wang JL; Dong YH; Chen HC; Wu LC; Chang CH
    PLoS Med; 2019 Sep; 16(9):e1002894. PubMed ID: 31518344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
    Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
    Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel machine learning models outperform risk scores in predicting hepatocellular carcinoma in patients with chronic viral hepatitis.
    Wong GL; Hui VW; Tan Q; Xu J; Lee HW; Yip TC; Yang B; Tse YK; Yin C; Lyu F; Lai JC; Lui GC; Chan HL; Yuen PC; Wong VW
    JHEP Rep; 2022 Mar; 4(3):100441. PubMed ID: 35198928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infection with hepatitis viruses, FIB-4 index and risk of hepatocellular carcinoma in southern Italy: a population-based cohort study.
    Fusco M; Piselli P; Virdone S; Di Cicco P; Scognamiglio P; De Paoli P; Ciullo V; Verdirosi D; D'Orazio M; Dal Maso L; Girardi E; Franceschi S; Serraino D
    Infect Agent Cancer; 2016; 11():54. PubMed ID: 27822295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective study on the risk of hepatocellular carcinoma among hepatitis C virus-positive blood donors focusing on demographic factors, alanine aminotransferase level at donation and interaction with hepatitis B virus.
    Tanaka H; Tsukuma H; Yamano H; Oshima A; Shibata H
    Int J Cancer; 2004 Dec; 112(6):1075-80. PubMed ID: 15386355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
    Chen DS
    Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictability of liver-related seromarkers for the risk of hepatocellular carcinoma in chronic hepatitis B patients.
    Lin YJ; Lee MH; Yang HI; Jen CL; You SL; Wang LY; Lu SN; Liu J; Chen CJ
    PLoS One; 2013; 8(4):e61448. PubMed ID: 23613855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.